NCT03775200: The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
- State
- Completed
- Phase
- Phase 2
- People
- 233 taking part
- Started
- 1 Mar 2019
- Primary completion
- 30 Jul 2021
- Arms
- Low dose, Medium dose, High dose
- Results
- Posted on the registry
- 13 Dec 2018: Trial registered
- 1 Mar 2019: Trial started
- 27 Sep 2021: Trial completed
- 24 Apr 2023: Trial results posted